Cite
Thompson AGB, Anastasiadis P, Druyeh R, et al. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021;26(10):5955-5966doi: 10.1038/s41380-021-01045-w.
Thompson, A. G. B., Anastasiadis, P., Druyeh, R., Whitworth, I., Nayak, A., Nihat, A., Mok, T. H., Rudge, P., Wadsworth, J. D. F., Rohrer, J., Schott, J. M., Heslegrave, A., Zetterberg, H., Collinge, J., Jackson, G. S., & Mead, S. (2021). Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Molecular psychiatry, 26(10), 5955-5966. https://doi.org/10.1038/s41380-021-01045-w
Thompson, Andrew G B, et al. "Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases." Molecular psychiatry vol. 26,10 (2021): 5955-5966. doi: https://doi.org/10.1038/s41380-021-01045-w
Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Nayak A, Nihat A, Mok TH, Rudge P, Wadsworth JDF, Rohrer J, Schott JM, Heslegrave A, Zetterberg H, Collinge J, Jackson GS, Mead S. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021 Oct;26(10):5955-5966. doi: 10.1038/s41380-021-01045-w. Epub 2021 Mar 05. PMID: 33674752.
Copy
Download .nbib